Skip to content

A Trial of Online LGBTQ-affirmative Cognitive Behavioral Therapy to Reduce Depression and Associated Health Risks Among Young Adults

A Randomized Controlled Trial of Online LGBTQ-affirmative Cognitive Behavioral Therapy to Reduce Depression and Associated Health Risks Among Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04408469
Enrollment
120
Registered
2020-05-29
Start date
2020-05-31
Completion date
2022-02-18
Last updated
2024-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LGBTQ, Sexual Behavior

Keywords

on-line intervention

Brief summary

This study is to test the efficacy of an online CBT intervention (EQuIP) that addresses the pathways through which minority stress compromises LGBTQ young adults' co-occurring mental (e.g., depression) and behavioral (e.g., substance use, condomless anal sex) health problems. This purpose of this study is to determine if the treatment is efficacious when delivered online and if its efficacy exceeds that of the self-monitoring control.

Detailed description

To evaluate the preliminary efficacy of an LGBTQ-affirmative online CBT treatment and whether such an LGBTQ-affirmative focus adds benefit, a 2-arm RCT that would examine (1) whether online EQuIP demonstrates significant mental health improvements compared to self-monitoring of stress and mood, and (2) whether participant baseline LGBTQ-specific stress exposure moderates treatment efficacy, such that participants with the most LGBTQ-specific stress exposure benefit more from online EQuIP than self-monitoring of stress and mood. The primary outcomes are depressive symptoms, anxiety symptoms, substance abuse, sexual risk behavior, and suicidality, all of which disproportionally affect LGBTQ young adults. Secondary outcomes include hypothesized cognitive, affective, and behavioral minority stress mechanisms, such as internalized homophobia, rejection sensitivity, concealment, social isolation, and emotional dysregulation. Participants will be randomized to either self-monitoring control or Online EQuIP group. Self-monitoring control: In this control condition, participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey. This type of self-monitoring has been shown to yield improvement in behavioral health outcomes. Self-reporting LGBTQ stress experiences has also been shown to produce reductions in depression symptoms over time. Participants will record these experiences once per week for 10 weeks. Online EQuIP: This online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks. Modules contain weekly psychoeducational text and vignettes about minority stress and mental health; brief videos illustrating the CBT skills; and homework exercises that therapists review and provide feedback on. Homework exercises include weekly tracking of stressful situations and mood, practicing new skills (e.g., mindfulness, cognitive restructuring), and exercises related to considering the origins of stress and negative emotions that participants may be experiencing. Therapists provide feedback after each homework assignment, including reviewing each participant's treatment goals as part of the first session's homework. Therapists who support this condition will be instructed to incorporate LGBTQ-specific content and feedback into homework reviews. Therapists will either be postdoctoral fellows in the Pachankis lab or clinical/counseling psychology interns/externs in the Pachankis lab who possess an advanced degree in a mental health field with significant prior experience treating LGBTQ young adults with mental health concerns. Modules were adapted directly from the in-person materials (e.g., therapist manual, participant handouts) used in our previously successful trials of this treatment. A team of six therapists and supervisors of the original in-person treatment adapted the text for the online modules, including realistic vignettes and easy-to-follow skills training. A video production company created accompanying videos with our clinical team's close input. In preparation for this RCT, the online EQuIP treatment was delivered to 14 LGBTQ young adults who meet all eligibility criteria for the full trial. The purpose of this initial test was to ensure acceptability of the treatment content and usability of the technical platform.

Interventions

BEHAVIORALOnline EQuIP

This online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.

Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* identify as lesbian, bisexual, gay, or another sexual minority identity (e.g., pansexual, demisexual) * past-week symptoms of depression or anxiety using the Brief Symptom Inventory-4 cutoff of 2.5 on either the depression subscale or anxiety subscale * weekly access to internet on a laptop, desktop, or tablet device * ability to read, write, and speak in English * provision of informed consent.

Exclusion criteria

* current active suicidality or homicidality (defined as active intent or concrete plan, as opposed to passive suicidal ideation) * evidence of active untreated mania, psychosis, or gross cognitive impairment - current enrollment in an intervention study * current enrollment in intensive mental health treatment (i.e., receiving mental health treatment more than once per month or 8 or more sessions of CBT within the past year.

Design outcomes

Primary

MeasureTime frameDescription
Change in DistressBaseline, 4 months, 8 monthsDistress will be measured using the Brief Symptom Inventory (BSI). The BSI is an 18 item measure that uses a 0-4 rating scale for each item. An overall score of 72 would be the highest possible score on the measure and would indicate an extreme level of overall distress.
Change in DepressionBaseline, 4 months, 8 monthsDepression will be measured using the Center for Epidemiological Studies -- Depression Scale (CESD). This 20-item measure uses a 0-3 rating (Rarely or none of the time - Most or all of the time) scale and sums across the items with items 3, 11, 14, and 16 reversed. for a minimum score of 0 and a maximum score of 60. Higher scores indicate greater severity of depression. In cases with internally missing data (items not answered), the sums are computed after imputation of the missing values: # items on scale / # actually answered, multiplied by the sum obtained from the answered items. A higher score indicates more depressive symptomatology during the past week.
Change in Depression SeverityBaseline, 4 months, 8 monthsDepression severity will be measured using the Overall Depression Severity & Impairment Scale (ODSIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the severity of depression.
Change in Anxiety SymptomsBaseline, 4 months, 8 monthsAnxiety symptoms will be measured by the Overall Anxiety Severity & Impairment Scale (OASIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the presence of anxiety symptoms.
Number of Participants Reporting Any Alcohol UseBaseline, 4 months, 8 monthsAlcohol use in participants will be assessed using the Alcohol Use Disorders Identification (AUDIT) instrument. Any alcohol use over the past 3 months will be measured through the first item of the instrument (How often, during the last 3 months did you have a drink containing alcohol?) with the creation of a binary variable (1 = any alcohol use, 0 = no alcohol use).
Number of Participants Reporting Any Suicidal IdeationBaseline, 4 months, 8 monthsSuicidal ideation will be measured using the Suicidal Ideation Attributes Scale (SIDAS). Any suicidal ideation was assessed through the first item of this scale (In the past month, how often have you had thoughts about suicide?) with the creation of a binary variable (1 = any suicidal ideation, 0 = no suicidal ideation).
Number of Participants Reporting Any Sexual Risk BehaviorBaseline, 4 months, 8 monthsSexual risk behavior is defined as: condomless anal or vaginal/frontal sex \[not counting the sole use of prosthetics\] in the absence of PrEP, with any HIV+ partner \[except primary HIV+ partners with a known undetectable viral load\] or status-unknown partner. A binary variable of any sexual risk behavior was constructed from reports of past-90 day sexual behavior (1 = any sexual risk behavior, 0 = no sexual risk behavior).

Countries

United States

Participant flow

Recruitment details

Recruitment started in May 2020 and ended in May 2021. Participants for this study were recruited from social media, mobile dating apps, LGBTQ community organizations, and via peer recruitment and referral.

Participants by arm

ArmCount
Online EQuIP
The online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks. Online EQuIP: This online CBT treatment consists of 10 weekly modules that participants will complete over the course of 10 weeks.
60
Self-Monitoring
Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks Self-monitoring control: Participants will be asked to indicate their past 7-day mood; stress experiences; and mental and behavioral health on an online survey experience once per week for 10 weeks
60
Total120

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDismissal due to ineligibility01
Overall StudyLost to Follow-up69
Overall StudyWithdrawal by Subject61

Baseline characteristics

CharacteristicSelf-MonitoringOnline EQuIPTotal
Age, Continuous22.03 years
STANDARD_DEVIATION 3.51
21.83 years
STANDARD_DEVIATION 3
21.93 years
STANDARD_DEVIATION 3.25
Difficulty Meeting Basic Needs
Not very hard
33 Participants32 Participants65 Participants
Difficulty Meeting Basic Needs
Somewhat hard
18 Participants26 Participants44 Participants
Difficulty Meeting Basic Needs
Very hard
9 Participants2 Participants11 Participants
Education Degree
4-year college degree
16 Participants16 Participants32 Participants
Education Degree
Advanced graduate school degree
1 Participants1 Participants2 Participants
Education Degree
Associate's degree
2 Participants1 Participants3 Participants
Education Degree
High school diploma or GED
9 Participants4 Participants13 Participants
Education Degree
Less than high school
1 Participants1 Participants2 Participants
Education Degree
Some college
17 Participants24 Participants41 Participants
Education Degree
Some graduate school
2 Participants4 Participants6 Participants
Education Degree
Some high school
12 Participants9 Participants21 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
11 Participants11 Participants22 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
49 Participants49 Participants98 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Financial Worry3.23 score on a scale
STANDARD_DEVIATION 1.17
3.23 score on a scale
STANDARD_DEVIATION 1.01
3.23 score on a scale
STANDARD_DEVIATION 1.09
Race/Ethnicity, Customized
Race/ethnicity
American Indian or Alaskan Native
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race/ethnicity
Asian
8 Participants12 Participants20 Participants
Race/Ethnicity, Customized
Race/ethnicity
Black/African American
2 Participants1 Participants3 Participants
Race/Ethnicity, Customized
Race/ethnicity
Multiracial/Multiple Races
11 Participants9 Participants20 Participants
Race/Ethnicity, Customized
Race/ethnicity
Native Hawaiian/Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race/ethnicity
Other
1 Participants3 Participants4 Participants
Race/Ethnicity, Customized
Race/ethnicity
White, Hispanic/Latinx
7 Participants6 Participants13 Participants
Race/Ethnicity, Customized
Race/ethnicity
White, Non-Hispanic/Latinx
30 Participants29 Participants59 Participants
Sex Assigned at Birth
Female
49 Participants42 Participants91 Participants
Sex Assigned at Birth
Intersex
1 Participants1 Participants2 Participants
Sex Assigned at Birth
Male
10 Participants17 Participants27 Participants
Sex/Gender, Customized
Gender identity
Cisgender man
5 Participants10 Participants15 Participants
Sex/Gender, Customized
Gender identity
Cisgender woman
29 Participants22 Participants51 Participants
Sex/Gender, Customized
Gender identity
Nonbinary (e.g., genderqueer, agender, gender fluid)
12 Participants17 Participants29 Participants
Sex/Gender, Customized
Gender identity
Other
4 Participants5 Participants9 Participants
Sex/Gender, Customized
Gender identity
Transgender man
8 Participants3 Participants11 Participants
Sex/Gender, Customized
Gender identity
Transgender woman
2 Participants3 Participants5 Participants
Sexual Orientation
Asexual
3 Participants3 Participants6 Participants
Sexual Orientation
Bisexual
20 Participants21 Participants41 Participants
Sexual Orientation
Gay
8 Participants11 Participants19 Participants
Sexual Orientation
Lesbian
14 Participants6 Participants20 Participants
Sexual Orientation
Other
1 Participants4 Participants5 Participants
Sexual Orientation
Pansexual
4 Participants4 Participants8 Participants
Sexual Orientation
Queer
10 Participants11 Participants21 Participants
U.S. Region
Midwest
10 Participants11 Participants21 Participants
U.S. Region
Northeast
13 Participants9 Participants22 Participants
U.S. Region
South
25 Participants28 Participants53 Participants
U.S. Region
West
12 Participants12 Participants24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 600 / 60
other
Total, other adverse events
1 / 600 / 60
serious
Total, serious adverse events
0 / 601 / 60

Outcome results

Primary

Change in Anxiety Symptoms

Anxiety symptoms will be measured by the Overall Anxiety Severity & Impairment Scale (OASIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the presence of anxiety symptoms.

Time frame: Baseline, 4 months, 8 months

Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.

ArmMeasureGroupValue (MEAN)Dispersion
Online EQuIPChange in Anxiety SymptomsBaseline9.12 score on a scaleStandard Error 0.39
Online EQuIPChange in Anxiety Symptoms4-month post-baseline7.32 score on a scaleStandard Error 0.53
Online EQuIPChange in Anxiety Symptoms8-month post-baseline7.25 score on a scaleStandard Error 0.52
Self-MonitoringChange in Anxiety SymptomsBaseline8.97 score on a scaleStandard Error 0.44
Self-MonitoringChange in Anxiety Symptoms4-month post-baseline7.45 score on a scaleStandard Error 0.51
Self-MonitoringChange in Anxiety Symptoms8-month post-baseline7.52 score on a scaleStandard Error 0.6
Primary

Change in Depression

Depression will be measured using the Center for Epidemiological Studies -- Depression Scale (CESD). This 20-item measure uses a 0-3 rating (Rarely or none of the time - Most or all of the time) scale and sums across the items with items 3, 11, 14, and 16 reversed. for a minimum score of 0 and a maximum score of 60. Higher scores indicate greater severity of depression. In cases with internally missing data (items not answered), the sums are computed after imputation of the missing values: # items on scale / # actually answered, multiplied by the sum obtained from the answered items. A higher score indicates more depressive symptomatology during the past week.

Time frame: Baseline, 4 months, 8 months

Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.

ArmMeasureGroupValue (MEAN)Dispersion
Online EQuIPChange in DepressionBaseline14.17 score on a scaleStandard Error 0.36
Online EQuIPChange in Depression4-month post-baseline12.68 score on a scaleStandard Error 0.57
Online EQuIPChange in Depression8-month post-baseline12.44 score on a scaleStandard Error 0.48
Self-MonitoringChange in DepressionBaseline15.41 score on a scaleStandard Error 0.47
Self-MonitoringChange in Depression4-month post-baseline13.45 score on a scaleStandard Error 0.5
Self-MonitoringChange in Depression8-month post-baseline13.38 score on a scaleStandard Error 0.5
Primary

Change in Depression Severity

Depression severity will be measured using the Overall Depression Severity & Impairment Scale (ODSIS). This 5 item measure uses a 0-4 rating scale and sums across the items for a maximum score of 20. The higher the score, the greater the severity of depression.

Time frame: Baseline, 4 months, 8 months

Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.

ArmMeasureGroupValue (MEAN)Dispersion
Online EQuIPChange in Depression SeverityBaseline7.20 score on a scaleStandard Error 0.54
Online EQuIPChange in Depression Severity4-month post-baseline6.07 score on a scaleStandard Error 0.73
Online EQuIPChange in Depression Severity8-month post-baseline6.15 score on a scaleStandard Error 0.74
Self-MonitoringChange in Depression SeverityBaseline8.40 score on a scaleStandard Error 0.58
Self-MonitoringChange in Depression Severity4-month post-baseline6.98 score on a scaleStandard Error 0.58
Self-MonitoringChange in Depression Severity8-month post-baseline6.63 score on a scaleStandard Error 0.73
Primary

Change in Distress

Distress will be measured using the Brief Symptom Inventory (BSI). The BSI is an 18 item measure that uses a 0-4 rating scale for each item. An overall score of 72 would be the highest possible score on the measure and would indicate an extreme level of overall distress.

Time frame: Baseline, 4 months, 8 months

Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.

ArmMeasureGroupValue (MEAN)Dispersion
Online EQuIPChange in DistressBaseline1.43 score on a scaleStandard Error 0.07
Online EQuIPChange in Distress4-month Post-baseline1.22 score on a scaleStandard Error 0.11
Online EQuIPChange in Distress8-month Post-baseline1.07 score on a scaleStandard Error 0.1
Self-MonitoringChange in DistressBaseline1.57 score on a scaleStandard Error 0.09
Self-MonitoringChange in Distress4-month Post-baseline1.34 score on a scaleStandard Error 0.11
Self-MonitoringChange in Distress8-month Post-baseline1.21 score on a scaleStandard Error 0.09
Primary

Number of Participants Reporting Any Alcohol Use

Alcohol use in participants will be assessed using the Alcohol Use Disorders Identification (AUDIT) instrument. Any alcohol use over the past 3 months will be measured through the first item of the instrument (How often, during the last 3 months did you have a drink containing alcohol?) with the creation of a binary variable (1 = any alcohol use, 0 = no alcohol use).

Time frame: Baseline, 4 months, 8 months

Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Online EQuIPNumber of Participants Reporting Any Alcohol UseBaseline42 Participants
Online EQuIPNumber of Participants Reporting Any Alcohol Use4-month post-baseline28 Participants
Online EQuIPNumber of Participants Reporting Any Alcohol Use8-month post-baseline34 Participants
Self-MonitoringNumber of Participants Reporting Any Alcohol UseBaseline41 Participants
Self-MonitoringNumber of Participants Reporting Any Alcohol Use4-month post-baseline36 Participants
Self-MonitoringNumber of Participants Reporting Any Alcohol Use8-month post-baseline34 Participants
Primary

Number of Participants Reporting Any Sexual Risk Behavior

Sexual risk behavior is defined as: condomless anal or vaginal/frontal sex \[not counting the sole use of prosthetics\] in the absence of PrEP, with any HIV+ partner \[except primary HIV+ partners with a known undetectable viral load\] or status-unknown partner. A binary variable of any sexual risk behavior was constructed from reports of past-90 day sexual behavior (1 = any sexual risk behavior, 0 = no sexual risk behavior).

Time frame: Baseline, 4 months, 8 months

Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Online EQuIPNumber of Participants Reporting Any Sexual Risk BehaviorBaseline4 Participants
Online EQuIPNumber of Participants Reporting Any Sexual Risk Behavior4-month post-baseline2 Participants
Online EQuIPNumber of Participants Reporting Any Sexual Risk Behavior8-month post-baseline4 Participants
Self-MonitoringNumber of Participants Reporting Any Sexual Risk BehaviorBaseline3 Participants
Self-MonitoringNumber of Participants Reporting Any Sexual Risk Behavior4-month post-baseline4 Participants
Self-MonitoringNumber of Participants Reporting Any Sexual Risk Behavior8-month post-baseline3 Participants
Primary

Number of Participants Reporting Any Suicidal Ideation

Suicidal ideation will be measured using the Suicidal Ideation Attributes Scale (SIDAS). Any suicidal ideation was assessed through the first item of this scale (In the past month, how often have you had thoughts about suicide?) with the creation of a binary variable (1 = any suicidal ideation, 0 = no suicidal ideation).

Time frame: Baseline, 4 months, 8 months

Population: The decrease in participants from baseline to post-baseline assessments reflect withdrawals, participants lost to follow-up, and participants dismissed from the study.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Online EQuIPNumber of Participants Reporting Any Suicidal IdeationBaseline37 Participants
Online EQuIPNumber of Participants Reporting Any Suicidal Ideation4-month post-baseline25 Participants
Online EQuIPNumber of Participants Reporting Any Suicidal Ideation8-month post-baseline28 Participants
Self-MonitoringNumber of Participants Reporting Any Suicidal IdeationBaseline35 Participants
Self-MonitoringNumber of Participants Reporting Any Suicidal Ideation4-month post-baseline24 Participants
Self-MonitoringNumber of Participants Reporting Any Suicidal Ideation8-month post-baseline25 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026